Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-focused biotechnology company developing ...
The next generation in skin resurfacing technology is available to Australian health care practitioners beginning 1 September ...
The table inside ranks the 20 biggest percentage winners and losers among stocks in the ASX300 at the end of each trading day ...
TwoTen Ballarat Pty Ltd ACN 653 946 760 (the Issuer) is seeking to raise a total of AUD 48,055,484 in funds by the issue of loan notes, according to an announcement today by the underwriter Banner ...
AI data centre infrastructure's burgeoning energy needs strengthen the long-term uranium outlook, while Boss and Paladin face contrasting operational, funding and valuation challenges ...
FNArena provides a weekly update of Listed Investment Companies (LICs) & Listed Investment Trusts (LITs) on the ASX in the ...
September is historically the weakest month for stocks, and on average the S&P500 falls -1.1%. The Australian market eased on ...
Poor trading results from a range of retailers show that, on a per capita basis, the consumer is already under pressure, so ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results